Amdocs (DOX) Financials

$91.56 -0.10 (-0.11%)

Closing price 05/30/2025 04:00 PM Eastern

Extended Trading

$92.00 +0.44 (+0.48%)

As of 05/30/2025 05:06 PM Eastern

Annual Income Statements for Amdocs

This table shows Amdocs' income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Period end date	9/30/2024	9/30/2023	9/30/2022	9/30/2021	9/30/2020	9/30/2019	9/30/2018	9/30/2017	9/30/2016	9/30/2015	9/30/2014
Net Income / (Loss) Attributable to Common Shareholders	493	541	550	688	498	479	354	437	409	446	422
Consolidated Net Income / (Loss)	496	543	550	688	498	479	354	437	409	446	422
Net Income / (Loss) Continuing Operations	496	543	550	688	498	479	354	437	409	446	422
Total Pre-Tax Income	591	636	648	814	583	568	422	513	485	513	490
Total Operating Income	629	654	665	599	595	570	428	517	483	516	496
Total Gross Profit	1,755	1,728	1,619	1,478	1,413	1,433	1,380	1,359	1,310	1,294	1,257
Total Revenue	5,005	4,888	4,577	4,289	4,169	4,087	3,975	3,867	3,718	3,644	3,564
Operating Revenue	5,005	4,888	4,577	4,289	4,169	4,087	3,975	3,867	3,718	3,644	3,564
Total Cost of Revenue	3,250	3,160	2,958	2,811	2,756	2,653	2,595	2,508	2,408	2,349	2,307
Operating Cost of Revenue	3,250	3,160	2,958	2,811	2,756	2,653	2,595	2,508	2,408	2,349	2,307
Total Operating Expenses	1,127	1,074	954	879	819	864	951	842	827	778	761
Selling, General & Admin Expense	573	571	529	487	459	492	481	473	465	440	445
Research & Development Expense	361	375	355	313	282	274	277	259	252	255	258
Amortization Expense	62	57	71	79	78	97	108	110	110	70	58
Restructuring Charge	131	71	0.00	0.00	-	-	-	-	-	13	0.00
Total Other Income / (Expense), net	-38	-18	-16	216	-11	-1.86	-6.77	-4.42	1.56	-2.54	-6.10
Other Income / (Expense), net	-38	-18	-16	216	-11	-1.86	-	-4.42	-	-	-
Income Tax Expense	95	93	99	126	85	88	67	76	75	67	67
Net Income / (Loss) Attributable to Noncontrolling Interest	3.12	2.25	0.00	0.00	-	-	-	-	-	-	-
Basic Earnings per Share	$4.27	$4.52	$4.47	$5.36	$3.73	$3.49	$2.49	$2.99	$2.74	$2.89	$2.65
Weighted Average Basic Shares Outstanding	112.89M	117.35M	120.84M	124.87M	131.54M	134.77M	140.18M	144.39M	147.13M	151.15M	156.70M
Diluted Earnings per Share	$4.25	$4.49	$4.44	$5.32	$3.71	$3.47	$2.47	$2.96	$2.71	$2.85	$2.62
Weighted Average Diluted Shares Outstanding	112.89M	117.35M	120.84M	124.87M	131.54M	134.77M	140.18M	144.39M	147.13M	151.15M	156.70M
Weighted Average Basic & Diluted Shares Outstanding	112.89M	117.35M	120.84M	124.87M	131.54M	134.77M	140.18M	144.39M	147.13M	151.15M	156.70M
Cash Dividends to Common per Share	$1.87	$1.70	$1.55	$1.41	$1.27	$1.11	$0.97	$0.86	$0.76	$0.67	$0.60

No quarterly income statements for Amdocs are available.

This table details how cash moves in and out of Amdocs' business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Period end date	9/30/2024	9/30/2023	9/30/2022	9/30/2021	9/30/2020	9/30/2019	9/30/2018	9/30/2017	9/30/2016	9/30/2015	9/30/2014
Net Change in Cash & Equivalents	-174	-53	-136	-274	512	53	-231	-119	-267	-68	89
Net Cash From Operating Activities	724	823	757	926	658	656	557	636	620	773	709
Net Cash From Continuing Operating Activities	724	823	757	926	658	656	557	636	620	773	709
Net Income / (Loss) Continuing Operations	496	543	550	688	498	479	354	437	409	446	422
Consolidated Net Income / (Loss)	496	543	550	688	498	479	354	437	409	446	422
Depreciation Expense	193	196	225	209	198	206	211	215	212	175	163
Amortization Expense	0.60	0.58	0.56	0.55	0.14	0.00	0.00	-	-	-	-
Non-Cash Adjustments To Reconcile Net Income	110	92	65	-170	35	39	49	40	36	39	42
Changes in Operating Assets and Liabilities, net	-76	-9.07	-82	198	-73	-68	-57	-55	-37	113	83
Net Cash From Investing Activities	-127	-224	-263	-329	-462	-87	-362	-185	-441	-380	-299
Net Cash From Continuing Investing Activities	-127	-224	-263	-329	-462	-87	-362	-185	-441	-380	-299
Purchase of Property, Plant & Equipment	-105	-124	-227	-210	-206	-128	-231	-133	-130	-121	-112
Acquisitions	-87	-122	-24	-143	-249	-61	-355	-18	-283	-263	-181
Purchase of Investments	-9.06	0.00	-34	-277	-0.75	0.00	-76	-282	-371	-250	-390
Sale of Property, Plant & Equipment	0.00	0.00	0.00	0.00	-	-	-	-	-	-	-
Divestitures	0.00	0.00	10	289	0.00	0.00	-	-	-	-	-
Sale and/or Maturity of Investments	69	26	22	18	0.00	101	303	278	362	253	379
Other Investing Activities, net	5.32	-4.30	-8.53	-6.08	-6.10	0.62	-3.16	-30	-19	1.41	3.87
Net Cash From Financing Activities	-771	-651	-630	-871	315	-517	-426	-570	-446	-461	-322
Net Cash From Continuing Financing Activities	-771	-651	-630	-871	315	-517	-426	-570	-446	-461	-322
Repurchase of Common Equity	-563	-490	-508	-680	-361	-398	-419	-341	-413	-454	-372
Payment of Dividends	-216	-201	-186	-177	-164	-152	-87	-122	-109	-101	-91
Other Financing Activities, net	8.17	39	65	87	96	34	81	92	96	84	132
Cash Interest Paid	35	19	17	19	5.39	7.35	2.01	1.15	0.58	0.55	0.63
Cash Income Taxes Paid	188	156	80	146	45	76	56	68	50	51	59

No quarterly cash flow statements for Amdocs are available.

This table presents Amdocs' assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Period end date	9/30/2024	9/30/2023	9/30/2022	9/30/2021	9/30/2020	9/30/2019	9/30/2018	9/30/2017	9/30/2016	9/30/2015	9/30/2014
Total Assets	6,386	6,426	6,390	6,512	6,342	5,293	5,348	5,279	5,331	5,325	5,185
Total Current Assets	1,771	1,912	2,003	2,067	2,075	1,676	1,721	2,048	2,100	2,378	2,424
Cash & Equivalents	346	520	573	709	983	472	419	650	769	1,036	1,103
Short-Term Investments	168	222	245	257	0.75	0.00	100	330	327	318	321
Accounts Receivable	1,028	944	947	867	861	988	972	865	819	715	716
Prepaid Expenses	228	225	238	235	230	216	230	204	186	159	135
Plant, Property, & Equipment, net	756	791	794	699	608	525	497	356	332	309	289
Total Noncurrent Assets	3,859	3,723	3,593	3,746	3,659	3,092	3,131	2,875	2,899	2,637	2,472
Goodwill	2,845	2,749	2,663	2,623	2,579	2,463	2,445	2,221	2,212	2,049	1,925
Intangible Assets	161	182	178	259	296	205	265	177	282	253	181
Other Noncurrent Operating Assets	854	793	752	864	784	424	420	477	406	336	366
Total Liabilities & Shareholders' Equity	6,386	6,426	6,390	6,512	6,342	5,293	5,348	5,279	5,331	5,325	5,185
Total Liabilities	2,887	2,859	2,830	2,877	2,676	1,750	1,856	1,705	1,878	1,918	1,789
Total Current Liabilities	1,471	1,353	1,253	1,304	1,216	1,208	1,295	1,173	1,366	1,364	1,201
Accounts Payable	306	293	134	121	110	177	195	126	137	112	143
Accrued Expenses	779	635	613	612	594	648	707	668	612	609	422
Current Deferred Revenue	115	171	254	237	127	118	132	113	173	198	157
Current Employee Benefit Liabilities	231	215	209	274	227	266	261	265	244	224	221
Other Current Liabilities	40	40	43	59	59	0.00	-	-	-	-	-
Total Noncurrent Liabilities	1,416	1,505	1,577	1,573	1,460	542	561	532	512	554	589
Long-Term Debt	646	646	645	645	644	0.00	-	-	-	-	-
Noncurrent Deferred & Payable Income Tax Liabilities	198	253	312	305	258	208	225	219	227	306	311
Other Noncurrent Operating Liabilities	572	607	620	624	558	335	336	313	285	248	278
Total Equity & Noncontrolling Interests	3,499	3,567	3,560	3,635	3,665	3,542	3,492	3,574	3,454	3,407	3,396
Total Preferred & Common Equity	3,457	3,524	3,518	3,593	3,623	3,500	3,449	3,574	3,454	3,407	3,396
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	3,457	3,524	3,518	3,593	3,623	3,500	3,449	3,574	3,454	3,407	3,396
Common Stock	4,418	4,249	4,110	3,956	3,812	3,672	3,592	3,463	3,327	3,187	3,059
Retained Earnings	6,828	6,550	6,212	5,851	5,342	5,013	4,674	4,457	4,145	3,848	3,504
Treasury Stock	-7,784	-7,221	-6,732	-6,223	-5,543	-5,182	-4,784	-4,365	-4,025	-3,611	-3,157
Accumulated Other Comprehensive Income / (Loss)	-4.41	-53	-72	9.34	12	-2.55	-33	19	6.10	-17	-9.97
Noncontrolling Interest	42	43	43	43	43	43	43	0.00	-	-	-

No quarterly balance sheets for Amdocs are available.

This table displays calculated financial ratios and metrics derived from Amdocs' official financial filings.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Period end date	9/30/2024	9/30/2023	9/30/2022	9/30/2021	9/30/2020	9/30/2019	9/30/2018	9/30/2017	9/30/2016	9/30/2015	9/30/2014
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	2.40%	6.79%	6.72%	2.87%	2.02%	2.81%	2.78%	4.01%	2.05%	2.24%	6.51%
EBITDA Growth	-5.75%	-4.68%	-14.67%	30.93%	1.06%	20.97%	-12.13%	4.73%	0.61%	4.91%	-47.10%
EBIT Growth	-7.12%	-1.86%	-20.37%	39.60%	2.72%	32.59%	-16.50%	6.16%	-6.36%	4.10%	-48.54%
NOPAT Growth	-5.41%	-0.96%	11.32%	-0.29%	5.53%	33.58%	-18.27%	7.98%	-9.00%	4.91%	2.32%
Net Income Growth	-8.59%	-1.19%	-20.17%	38.27%	3.84%	35.29%	-18.87%	6.72%	-8.26%	5.70%	2.35%
EPS Growth	-5.35%	1.13%	-16.54%	43.40%	6.92%	40.49%	-16.55%	9.23%	-4.91%	8.78%	3.56%
Operating Cash Flow Growth	-11.94%	8.71%	-18.26%	40.67%	0.27%	17.79%	-12.40%	2.56%	-19.72%	8.93%	5.77%
Free Cash Flow Firm Growth	-22.83%	-3.02%	-20.59%	302.88%	-60.00%	2,195.26%	-104.53%	228.41%	-65.54%	-9.51%	2.62%
Invested Capital Growth	4.64%	2.44%	2.21%	-3.24%	11.54%	3.30%	14.58%	1.43%	12.54%	4.19%	1.53%
Revenue Q/Q Growth	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
EBITDA Q/Q Growth	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
EBIT Q/Q Growth	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
NOPAT Q/Q Growth	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Net Income Q/Q Growth	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
EPS Q/Q Growth	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Cash Flow Q/Q Growth	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Free Cash Flow Firm Q/Q Growth	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Invested Capital Q/Q Growth	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	35.07%	35.35%	35.38%	34.46%	33.90%	35.08%	34.71%	35.16%	35.24%	35.52%	35.27%
EBITDA Margin	15.68%	17.04%	19.09%	23.87%	18.75%	18.93%	16.09%	18.82%	18.69%	18.96%	18.48%
Operating Margin	12.56%	13.38%	14.53%	13.96%	14.27%	13.94%	10.78%	13.38%	12.99%	14.16%	13.91%
EBIT Margin	11.81%	13.02%	14.17%	18.99%	13.99%	13.90%	10.78%	13.26%	12.99%	14.16%	13.91%
Profit (Net Income) Margin	9.92%	11.11%	12.01%	16.05%	11.94%	11.73%	8.92%	11.30%	11.01%	12.25%	11.85%
Tax Burden Percent	83.97%	85.32%	84.75%	84.54%	85.35%	84.43%	84.07%	85.17%	84.45%	86.90%	86.23%
Interest Burden Percent	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	98.42%	100.00%	100.32%	99.51%	98.77%
Effective Tax Rate	16.03%	14.68%	15.25%	15.46%	14.65%	15.57%	15.93%	14.83%	15.55%	13.10%	13.77%
Return on Invested Capital (ROIC)	14.87%	16.27%	16.81%	15.02%	15.63%	15.92%	12.94%	17.10%	16.89%	20.13%	19.74%
ROIC Less NNEP Spread (ROIC-NNEP)	-164.59%	27.43%	22.44%	-49.97%	18.37%	16.23%	13.69%	17.50%	16.76%	20.32%	20.19%
Return on Net Nonoperating Assets (RNNOA)	-0.82%	-1.04%	-1.54%	3.84%	-1.81%	-2.29%	-2.90%	-4.67%	-4.96%	-7.02%	-7.09%
Return on Equity (ROE)	14.05%	15.24%	15.27%	18.86%	13.81%	13.63%	10.03%	12.43%	11.93%	13.12%	12.66%
Cash Return on Invested Capital (CROIC)	10.33%	13.86%	14.63%	18.32%	4.72%	12.67%	-0.66%	15.68%	5.09%	16.03%	18.22%
Operating Return on Assets (OROA)	9.23%	9.93%	10.05%	12.67%	10.03%	10.67%	8.06%	9.67%	9.07%	9.82%	9.80%
Return on Assets (ROA)	7.75%	8.47%	8.52%	10.71%	8.56%	9.01%	6.67%	8.23%	7.68%	8.49%	8.35%
Return on Common Equity (ROCE)	13.88%	15.05%	15.09%	18.64%	13.65%	13.47%	9.97%	12.43%	11.93%	13.12%	12.66%
Return on Equity Simple (ROE_SIMPLE)	14.36%	15.41%	15.62%	19.16%	13.74%	13.70%	10.28%	12.22%	11.85%	13.10%	12.43%
Net Operating Profit after Tax (NOPAT)	528	558	563	506	508	481	360	441	408	448	427
NOPAT Margin	10.55%	11.42%	12.31%	11.80%	12.18%	11.77%	9.06%	11.39%	10.97%	12.31%	11.99%
Net Nonoperating Expense Percent (NNEP)	179.45%	-11.15%	-5.62%	64.99%	-2.74%	-0.32%	-0.76%	-0.40%	0.13%	-0.19%	-0.45%
Return On Investment Capital (ROIC_SIMPLE)	12.73%	13.25%	13.40%	-	-	-	-	-	-	-	-
Cost of Revenue to Revenue	64.93%	64.65%	64.62%	65.54%	66.10%	64.92%	65.29%	64.85%	64.76%	64.48%	64.73%
SG&A Expenses to Revenue	11.45%	11.68%	11.55%	11.36%	11.00%	12.05%	12.10%	12.23%	12.50%	12.08%	12.49%
R&D to Revenue	7.21%	7.67%	7.75%	7.30%	6.77%	6.70%	6.96%	6.70%	6.79%	7.00%	7.24%
Operating Expenses to Revenue	22.51%	21.97%	20.85%	20.50%	19.64%	21.14%	23.93%	21.78%	22.24%	21.36%	21.36%
Earnings before Interest and Taxes (EBIT)	591	636	648	814	583	568	428	513	483	516	496
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	785	833	874	1,024	782	774	640	728	695	691	658
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	2.97	2.83	2.71	2.66	2.01	2.44	2.50	2.36	2.22	2.27	1.85
Price to Tangible Book Value (P/TBV)	22.74	16.84	14.08	13.42	9.73	10.26	11.66	7.17	8.00	6.99	4.88
Price to Revenue (P/Rev)	2.05	2.04	2.08	2.22	1.75	2.09	2.17	2.18	2.07	2.12	1.76
Price to Earnings (P/E)	20.81	18.47	17.34	13.86	14.62	17.80	24.30	19.30	18.77	17.32	14.90
Dividend Yield	2.14%	2.06%	2.03%	1.94%	2.35%	1.82%	1.63%	1.49%	1.49%	1.35%	1.51%
Earnings Yield	4.80%	5.41%	5.77%	7.21%	6.84%	5.62%	4.12%	5.18%	5.33%	5.77%	6.71%
Enterprise Value to Invested Capital (EV/IC)	2.88	2.86	2.77	2.80	2.07	2.64	2.74	2.87	2.65	2.90	2.33
Enterprise Value to Revenue (EV/Rev)	2.09	2.03	2.05	2.16	1.70	1.98	2.05	1.93	1.83	1.81	1.42
Enterprise Value to EBITDA (EV/EBITDA)	13.30	11.93	10.76	9.05	9.06	10.47	12.72	10.24	9.77	9.55	7.71
Enterprise Value to EBIT (EV/EBIT)	17.66	15.61	14.49	11.38	12.14	14.27	18.99	14.52	14.05	12.78	10.24
Enterprise Value to NOPAT (EV/NOPAT)	19.78	17.80	16.68	18.30	13.95	16.85	22.59	16.91	16.63	14.71	11.87
Enterprise Value to Operating Cash Flow (EV/OCF)	14.41	12.08	12.42	10.01	10.76	12.35	14.60	11.71	10.94	8.53	7.15
Enterprise Value to Free Cash Flow (EV/FCFF)	28.46	20.90	19.17	15.01	46.22	21.16	0.00	18.44	55.17	18.47	12.86
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.18	0.18	0.18	0.18	0.20	0.00	0.00	0.00	0.06	0.06	0.06
Long-Term Debt to Equity	0.18	0.18	0.18	0.18	0.18	0.00	0.00	0.00	0.00	0.00	0.00
Financial Leverage	0.01	-0.04	-0.07	-0.08	-0.10	-0.14	-0.21	-0.27	-0.30	-0.35	-0.35
Leverage Ratio	1.81	1.80	1.79	1.76	1.61	1.51	1.50	1.51	1.55	1.55	1.52
Compound Leverage Factor	1.81	1.80	1.79	1.76	1.61	1.51	1.48	1.51	1.56	1.54	1.50
Debt to Total Capital	15.59%	15.33%	15.34%	15.06%	16.87%	0.00%	0.00%	0.00%	5.47%	6.07%	5.82%
Short-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	2.27%	0.00%	0.00%	0.00%	5.47%	6.07%	5.82%
Long-Term Debt to Total Capital	15.59%	15.33%	15.34%	15.06%	14.61%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	1.02%	1.02%	1.01%	0.99%	0.96%	1.20%	1.24%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	83.39%	83.65%	83.65%	83.95%	82.16%	98.80%	98.76%	100.00%	94.53%	93.93%	94.18%
Debt to EBITDA	0.82	0.78	0.74	0.63	0.95	0.00	0.00	0.00	0.29	0.32	0.32
Net Debt to EBITDA	0.17	-0.12	-0.20	-0.31	-0.31	0.00	0.00	0.00	-1.29	-1.64	-1.84
Long-Term Debt to EBITDA	0.82	0.78	0.74	0.63	0.82	0.00	0.00	0.00	0.00	0.00	0.00
Debt to NOPAT	1.22	1.16	1.15	1.27	1.47	0.00	0.00	0.00	0.49	0.49	0.49
Net Debt to NOPAT	0.25	-0.17	-0.31	-0.63	-0.47	0.00	0.00	0.00	-2.20	-2.53	-2.84
Long-Term Debt to NOPAT	1.22	1.16	1.15	1.27	1.27	0.00	0.00	0.00	0.00	0.00	0.00
Altman Z-Score	4.78	4.72	4.57	4.46	3.93	5.48	5.11	5.40	4.70	4.66	4.34
Noncontrolling Interest Sharing Ratio	1.21%	1.20%	1.18%	1.16%	1.18%	1.22%	0.61%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	1.20	1.41	1.60	1.59	1.71	1.39	1.33	1.75	1.54	1.74	2.02
Quick Ratio	1.05	1.25	1.41	1.41	1.52	1.21	1.15	1.57	1.40	1.52	1.78
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	367	475	490	617	153	383	-18	404	123	357	394
Operating Cash Flow to CapEx	686.69%	661.48%	333.04%	439.94%	320.25%	512.45%	241.08%	476.87%	476.79%	641.16%	635.71%
Free Cash Flow to Firm to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Operating Cash Flow to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Operating Cash Flow Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.78	0.76	0.71	0.67	0.72	0.77	0.75	0.73	0.70	0.69	0.70
Accounts Receivable Turnover	5.07	5.17	5.05	4.96	4.51	4.17	4.33	4.59	4.85	5.09	5.11
Inventory Turnover	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fixed Asset Turnover	6.47	6.17	6.13	6.56	7.36	8.00	9.33	11.25	11.60	12.18	12.63
Accounts Payable Turnover	10.85	14.77	23.14	24.30	19.23	14.29	16.16	19.06	19.37	18.46	16.76
Days Sales Outstanding (DSO)	71.94	70.62	72.32	73.53	80.94	87.50	84.32	79.45	75.26	71.66	71.39
Days Inventory Outstanding (DIO)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Days Payable Outstanding (DPO)	33.66	24.70	15.77	15.02	18.98	25.54	22.58	19.15	18.84	19.78	21.78
Cash Conversion Cycle (CCC)	38.28	45.92	56.55	58.51	61.95	61.96	61.74	60.31	56.41	51.88	49.61
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	3,631	3,470	3,387	3,314	3,425	3,071	2,973	2,594	2,558	2,273	2,181
Invested Capital Turnover	1.41	1.43	1.37	1.27	1.28	1.35	1.43	1.50	1.54	1.64	1.65
Increase / (Decrease) in Invested Capital	161	83	73	-111	354	98	378	37	285	91	33
Enterprise Value (EV)	10,440	9,935	9,396	9,263	7,080	8,104	8,135	7,449	6,786	6,593	5,073
Market Capitalization	10,266	9,989	9,526	9,541	7,278	8,533	8,611	8,429	7,682	7,727	6,288
Book Value per Share	$29.46	$29.16	$28.17	$27.31	$26.88	$24.97	$23.89	$24.29	$22.85	$21.74	$21.22
Tangible Book Value per Share	$3.85	$4.91	$5.42	$5.41	$5.55	$5.94	$5.12	$7.99	$6.35	$7.05	$8.06
Total Capital	4,145	4,213	4,205	4,280	4,409	3,542	3,492	3,574	3,654	3,627	3,606
Total Debt	646	646	645	645	744	0.00	0.00	0.00	200	220	210
Total Long-Term Debt	646	646	645	645	644	0.00	0.00	0.00	0.00	0.00	0.00
Net Debt	132	-97	-173	-321	-240	-472	-519	-980	-896	-1,134	-1,214
Capital Expenditures (CapEx)	105	124	227	210	206	128	231	133	130	121	112
Debt-free, Cash-free Net Working Capital (DFCFNWC)	-214	-184	-68	-202	-26	-3.99	-93	-104	-161	-119	8.76
Debt-free Net Working Capital (DFNWC)	300	558	750	764	958	468	426	876	934	1,235	1,433
Net Working Capital (NWC)	300	558	750	764	858	468	426	876	734	1,015	1,223
Net Nonoperating Expense (NNE)	32	15	14	-182	9.76	1.57	5.69	3.77	-1.31	2.21	5.26
Net Nonoperating Obligations (NNO)	132	-97	-173	-321	-240	-472	-519	-980	-896	-1,134	-1,214
Total Depreciation and Amortization (D&A)	194	196	225	209	199	206	211	215	212	175	163
Debt-free, Cash-free Net Working Capital to Revenue	-4.28%	-3.77%	-1.48%	-4.71%	-0.61%	-0.10%	-2.35%	-2.69%	-4.34%	-3.28%	0.25%
Debt-free Net Working Capital to Revenue	6.00%	11.42%	16.40%	17.81%	22.99%	11.44%	10.71%	22.64%	25.13%	33.89%	40.22%
Net Working Capital to Revenue	6.00%	11.42%	16.40%	17.81%	20.59%	11.44%	10.71%	22.64%	19.75%	27.85%	34.33%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$4.27	$4.52	$4.47	$5.36	$3.73	$0.00	$2.49	$2.99	$2.74	$2.89	$2.65
Adjusted Weighted Average Basic Shares Outstanding	112.89M	117.35M	120.84M	124.87M	131.54M	0.00	140.18M	144.39M	147.13M	151.15M	159.01M
Adjusted Diluted Earnings per Share	$4.25	$4.49	$4.44	$5.32	$3.71	$0.00	$2.47	$2.96	$2.71	$2.85	$2.62
Adjusted Weighted Average Diluted Shares Outstanding	112.89M	117.35M	120.84M	124.87M	131.54M	0.00	140.18M	144.39M	147.13M	151.15M	161.37M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	112.89M	117.35M	120.84M	124.87M	131.54M	0.00	140.18M	144.39M	147.13M	151.15M	156.70M
Normalized Net Operating Profit after Tax (NOPAT)	638	618	563	506	508	481	432	441	408	460	427
Normalized NOPAT Margin	12.75%	12.65%	12.31%	11.80%	12.18%	11.77%	10.86%	11.39%	10.97%	12.62%	11.99%
Pre Tax Income Margin	11.81%	13.02%	14.17%	18.99%	13.99%	13.90%	10.61%	13.26%	13.04%	14.09%	13.74%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
NOPAT to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
EBIT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
NOPAT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	43.53%	37.03%	33.86%	25.78%	32.95%	31.79%	24.63%	27.82%	26.70%	22.59%	21.54%
Augmented Payout Ratio	156.99%	127.19%	126.40%	124.56%	105.45%	114.81%	142.92%	105.79%	127.70%	124.35%	109.67%

No quarterly metrics and ratios for Amdocs are available.

Frequently Asked Questions About Amdocs' Financials

When does Amdocs's financial year end?

According to the most recent income statement we have on file, Amdocs' fiscal year ends in September. Their fiscal year 2024 ended on September 30, 2024.

How has Amdocs' net income changed over the last 10 years?

Amdocs' net income appears to be on an upward trend, with a most recent value of $496.32 million in 2024, rising from $422.12 million in 2014. The previous period was $542.96 million in 2023. See Amdocs' forecast for analyst expectations on what’s next for the company.

What is Amdocs's operating income?

Amdocs's total operating income in 2024 was $628.61 million, based on the following breakdown:

Total Gross Profit: $1.76 billion
Total Operating Expenses: $1.13 billion

How has Amdocs revenue changed over the last 10 years?

Over the last 10 years, Amdocs' total revenue changed from $3.56 billion in 2014 to $5.00 billion in 2024, a change of 40.4%.

How much debt does Amdocs have?

Amdocs' total liabilities were at $2.89 billion at the end of 2024, a 1.0% increase from 2023, and a 61.3% increase since 2014.

How much cash does Amdocs have?

In the past 10 years, Amdocs' cash and equivalents has ranged from $346.09 million in 2024 to $1.10 billion in 2014, and is currently $346.09 million as of their latest financial filing in 2024.

How has Amdocs' book value per share changed over the last 10 years?

Over the last 10 years, Amdocs' book value per share changed from 21.22 in 2014 to 29.46 in 2024, a change of 38.9%.

Related Companies

This page (NASDAQ:DOX) was last updated on 6/1/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Amdocs (DOX) Financials

Frequently Asked Questions About Amdocs' Financials

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Amdocs (DOX) Financials

Annual Income Statements for Amdocs

Quarterly Income Statements for Amdocs

Annual Cash Flow Statements for Amdocs

Quarterly Cash Flow Statements for Amdocs

Annual Balance Sheets for Amdocs

Quarterly Balance Sheets for Amdocs

Annual Metrics And Ratios for Amdocs

Quarterly Metrics And Ratios for Amdocs

Frequently Asked Questions About Amdocs' Financials

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools